Low Birth Weight: A Novel Cardiovascular Risk Factor?

Ageliki Laina¹, Konstantinos Stellos^{2

3}

Affiliations

¹ Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Greece (A.L.).
² Cardiovascular Research Centre, Institute of Genetic Medicine, Newcastle University, United Kingdom (K.S.). konstantinos.stellos@ncl.ac.uk.
³ Cardiothoracic Centre, Newcastle upon Tyne Hospitals, NHS Foundation Trust, United Kingdom (K.S.).

Editorial

Ageliki Laina et al. Circ Genom Precis Med. 2018 Jun.

. 2018 Jun;11(6):e002163.

doi: 10.1161/CIRCGEN.118.002163.

Ageliki Laina¹, Konstantinos Stellos^{2

3}

¹ Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Greece (A.L.).
² Cardiovascular Research Centre, Institute of Genetic Medicine, Newcastle University, United Kingdom (K.S.). konstantinos.stellos@ncl.ac.uk.
³ Cardiothoracic Centre, Newcastle upon Tyne Hospitals, NHS Foundation Trust, United Kingdom (K.S.).

No abstract available

Keywords: DNA methylation; Editorials; birth weight; blood pressure; coronary artery disease; risk factors.

Comment on

Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease: Addressing the Barker Hypothesis With Mendelian Randomization.
Zanetti D, Tikkanen E, Gustafsson S, Priest JR, Burgess S, Ingelsson E. Zanetti D, et al. Circ Genom Precis Med. 2018 Jun;11(6):e002054. doi: 10.1161/CIRCGEN.117.002054. Circ Genom Precis Med. 2018. PMID: 29875125 Free PMC article.